https://www.marketscreener.com/quote/stock/VALERIO-THERAPEUTICS-17068163/news/Onxeo-Announces-Top-Line-Results-from-ReLive-Phase-III-Study-of-Livatag-in-Advanced-Hepatocellular-25097493/?utm_source=telegram&utm_medium=social&utm_campaign=share